FOXO3 and diffuse large B-cell lymphoma: In our results, FOXO3 was demonstrated to suppress the transcription of RASIP1 by binding to its promoter −690/-683 sequence, and the suppressive effects of FOXO3 on DLBCL cell behaviors were reversed by RASIP1.